Navigazzjoni
RĠPD (GDPR) > Premessa 161
Download PDF

Premessa 161

Recital 161

(161) Għall-finijiet ta’ kunsens għall-parteċipazzjoni f’attivitajiet ta’ riċerka xjentifika fi provi kliniċi għandhom japplikaw id-dispożizzjonijiet rilevanti tar-Regolament (UE) Nru 536/2014 tal-Parlament Ewropew u tal-Kunsill (15).

(161) For the purpose of consenting to the participation in scientific research activities in clinical trials, the relevant provisions of Regulation (EU) No 536/2014 of the European Parliament and of the Council [15] should apply.

(15) Regolament (UE) Nru 536/2014 tal-Parlament Ewropew u tal-Kunsill tas-16 ta’ April 2014 dwar il-provi kliniċi fuq prodotti mediċinali għall-użu mill-bniedem, u li jħassar id-Direttiva 2001/20/KE (ĠU L 158 27.5.2014, p. 1). https://eur-lex.europa.eu/legal-content/EN/AUTO/?uri=OJ:L:2014:158:TOC

[15] Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (OJ L 158, 27.5.2014, p. 1). https://eur-lex.europa.eu/legal-content/EN/AUTO/?uri=OJ:L:2014:158:TOC